Novel Drug Delivery Systems Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3850
Novel Drug Delivery Systems Market size is expected to grow significantly from 2019 to 2025.
Increasing need for control released, targeted and modulated drug delivery will propel business growth in forthcoming future. Extensive research and development procedures performed in pharmaceutical companies will provide innovative solutions to patients. Novel drug delivery systems enhance patient outcomes by delivering optimum dosage that eliminates risk of adverse effects. Moreover, it minimizes toxicity of medications and improvise efficacy. Thus, advantages obtained through novel drug delivery systems will augment its demand that will fuel market growth.
Technological advancements in novel drug delivery systems will rise its preference amongst patients that will prove beneficial for industry growth. Transition occurred in novel drug delivery systems through introduction of nano technology in pharmacy domain resulting development of several techniques helping patients to heal at faster pace. Technologically advanced novel drug delivery systems objective is to reduce drug degradation and loss, prevention of hazardous repercussions, etc. Thus, technological advancements will propel its demand thereby, driving business growth. However, stringent regulatory guidelines may hamper business growth up to certain extent.
Oral drug delivery systems segment is anticipated to witness lucrative growth over the forecast time period. High patient compliance, minimum sterility constraints, ease of production, flexibility in dosage form and cost effectiveness achieved through oral drug delivery systems will benefit market growth. Increasing prevalence of chronic diseases will further fuel segment growth. Additionally, technological advancements such as osmotic controlled release oral drug delivery system delivers drug at zero order rate thereby, enhancing patient outcome.
Targeted drug delivery systems segment had substantial revenue share in 2018 and it should enormously increase in near future. Targeted drug delivery emphasizes on specific tissues and organs that helps in achieving desired concentration. Currently discovered targeted drug delivery include protein, polymer and lipid technologies, that distributes optimally at the targeted area of the body. This type of drug delivery systems avoids external environment reaction, drug degradation and exposure to non-targeted sites. As a result, specificity obtained through targeted drug delivery system will escalate its demand, thereby driving segment growth.
North America novel drug delivery systems market is anticipated to witness significant growth over the forecast time frame. Increasing efforts undertaken by bio pharmaceutical companies to provide technologically advanced innovative solutions will rise its adoption. Moreover, increasing geriatric population susceptible to chronic disorders will fuel market growth. As a result, rising adoption rate coupled with increasing geriatric population will augment regional market growth.
Some of the major industry players operating in the novel drug delivery systems includes Abbott Laboratories, AstraZeneca, Bayer, F. Hoffmann-La Roche, Johnson & Johnson GlaxoSmithKline, Merck, Pfizer, Sanofi and Novartis. These industry players are implementing several strategies such as joint collaborations, mergers and acquisitions, new product launch, etc. These strategies help companies to gain more market share and sustain in the industry. For instance, in July 2018, Merck and InnoCore entered into a global cooperation agreement in order to offer InnoCore’s proprietary SynBiosys drug delivery platform. This strategy will make product widely available to patients, that will increase enable company to capture more market share.
Novel Drug Delivery Systems Market By Route of Administration, 2014-2025 (USD Million)
- Oral Drug Delivery Systems
- Injectable Drug Delivery Systems
- Pulmonary Drug Delivery Systems
- Transdermal Drug Delivery Systems
Novel Drug Delivery Systems Market By Mode of NDDS, 2014-2025 (USD Million)
- Targeted Drug Delivery Systems
- Controlled Drug Delivery Systems
- Modulated Drug Delivery Systems
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Abbott Laboratories
- F. Hoffmann-La Roche
- Johnson & Johnson
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.